SOPHiA GENETICS CEO Muken Ross Sells 422 Shares

What Happened Muken Ross, CEO of SOPHiA GENETICS (SOPH), sold 422 shares on 2026-09-21 at $8.33 per share, totaling approximately $3,515. The Form 4 reporting the sale was filed on 2026-09-22. The sale was executed to satisfy tax withholding obligations arising from restricted stock units that vested on 2026-09-18.

Key Details

• Transaction date and price: 2026-09-21 — 422 shares at $8.33 each.
• Total value: ≈ $3,515.
• Reported as a sale; footnote states the shares were sold to satisfy tax withholding related to RSU vesting on 2026-09-18.
• Sales were effected under a pre-established Rule 10b5-1(c) trading plan and were non-discretionary.
• Shares owned after the transaction: not specified in this Form 4.
• Filing timeliness: Form 4 filed 2026-09-22 (timely within reporting window).

Context This was a tax-withholding sale tied to RSU vesting and executed under a 10b5-1 plan, which are routine and typically do not indicate a change in the insider’s view of the company. For retail investors, purchases or discretionary sales usually carry more informational weight than automated withholding sales.